<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><description>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 18 Mar 2021 07:18:55 +0800</pubDate><image><url>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</url><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>T细胞导向疗法中双抗的空间因素</title><link>https://mp.weixin.qq.com/s/ynRiFkiJd-N-8ATWflR98A</link><description></description><content:encoded><![CDATA[T细胞导向疗法中双抗的空间因素]]></content:encoded><pubDate>Thu, 18 Mar 2021 06:16:50 +0800</pubDate></item><item><title>抗体药物的发展历程（1）-抗体的发现</title><link>https://mp.weixin.qq.com/s/QiXDASQqzPF900nMWZjS1g</link><description></description><content:encoded><![CDATA[抗体药物的发展历程（1）-抗体的发现]]></content:encoded><pubDate>Wed, 17 Mar 2021 06:13:32 +0800</pubDate></item><item><title>抗体药物的发展历程（2）-治疗性抗体的发展阶段</title><link>https://mp.weixin.qq.com/s/nGJnHCNk0OrwhZyxP8mCng</link><description></description><content:encoded><![CDATA[抗体药物的发展历程（2）-治疗性抗体的发展阶段]]></content:encoded><pubDate>Wed, 17 Mar 2021 06:13:32 +0800</pubDate></item><item><title>抗体药物的发展历程（3）-抗体的结构与分类</title><link>https://mp.weixin.qq.com/s/I4nWNp4WffenWXYCOaJSUA</link><description></description><content:encoded><![CDATA[抗体药物的发展历程（3）-抗体的结构与分类]]></content:encoded><pubDate>Wed, 17 Mar 2021 06:13:32 +0800</pubDate></item><item><title>抗体药物的发展历程（4）-抗体的筛选技术</title><link>https://mp.weixin.qq.com/s/4Iku_VR5A4l70ailtwZ9cg</link><description></description><content:encoded><![CDATA[抗体药物的发展历程（4）-抗体的筛选技术]]></content:encoded><pubDate>Wed, 17 Mar 2021 06:13:32 +0800</pubDate></item><item><title>抗体药物的发展历程（5）-小分子抗体药物</title><link>https://mp.weixin.qq.com/s/G9oydaQlSHT7UEojJe6WYA</link><description></description><content:encoded><![CDATA[抗体药物的发展历程（5）-小分子抗体药物]]></content:encoded><pubDate>Wed, 17 Mar 2021 06:13:32 +0800</pubDate></item><item><title>抗体药物的发展历程（6）-抗体偶联药物（ADC）</title><link>https://mp.weixin.qq.com/s/HoG7zGN-sLmel_WJyp0BKg</link><description></description><content:encoded><![CDATA[抗体药物的发展历程（6）-抗体偶联药物（ADC）]]></content:encoded><pubDate>Wed, 17 Mar 2021 06:13:32 +0800</pubDate></item><item><title>抗体药物的发展历程（7）-双特异性抗体</title><link>https://mp.weixin.qq.com/s/-V8wMnlpb8y1ix88N8aIYQ</link><description></description><content:encoded><![CDATA[抗体药物的发展历程（7）-双特异性抗体]]></content:encoded><pubDate>Wed, 17 Mar 2021 06:13:32 +0800</pubDate></item><item><title>抗体药物的发展历程（末章）创新-生物制药的未来</title><link>https://mp.weixin.qq.com/s/h5g33-HJn4iioRz2eqPhOg</link><description></description><content:encoded><![CDATA[抗体药物的发展历程（末章）创新-生物制药的未来]]></content:encoded><pubDate>Wed, 17 Mar 2021 06:13:32 +0800</pubDate></item><item><title>抗体肿瘤治疗的亚型选择</title><link>https://mp.weixin.qq.com/s/n8wpWGD89NuMulNm1Iph_g</link><description></description><content:encoded><![CDATA[抗体肿瘤治疗的亚型选择]]></content:encoded><pubDate>Tue, 16 Mar 2021 06:15:57 +0800</pubDate></item><item><title>再循环抗体的研究进展</title><link>https://mp.weixin.qq.com/s/eCvHQn9LhNShj0saI46oJQ</link><description></description><content:encoded><![CDATA[再循环抗体的研究进展]]></content:encoded><pubDate>Tue, 16 Mar 2021 06:15:57 +0800</pubDate></item><item><title>IgG4重链改造专利简述</title><link>https://mp.weixin.qq.com/s/E6hFWEB4Hn2EokuiQCXwgw</link><description></description><content:encoded><![CDATA[IgG4重链改造专利简述]]></content:encoded><pubDate>Tue, 16 Mar 2021 06:15:57 +0800</pubDate></item><item><title>盘点2021上市的抗体新药-（1）Evinacumab</title><link>https://mp.weixin.qq.com/s/JLtdjwAq-Za88fYirTaxuQ</link><description></description><content:encoded><![CDATA[盘点2021上市的抗体新药-（1）Evinacumab]]></content:encoded><pubDate>Mon, 15 Mar 2021 06:13:06 +0800</pubDate></item><item><title>人人学懂免疫学：第十六期</title><link>https://mp.weixin.qq.com/s/dCCjLFKmFs7iKO5SuEY3Yw</link><description></description><content:encoded><![CDATA[人人学懂免疫学：第十六期]]></content:encoded><pubDate>Sat, 13 Mar 2021 06:21:47 +0800</pubDate></item><item><title>人人学懂免疫学：第十七期</title><link>https://mp.weixin.qq.com/s/ij--4ycfKDovNAl2nPdzkg</link><description></description><content:encoded><![CDATA[人人学懂免疫学：第十七期]]></content:encoded><pubDate>Sat, 13 Mar 2021 06:21:47 +0800</pubDate></item><item><title>人人学懂免疫学：第十八期</title><link>https://mp.weixin.qq.com/s/MjdcQWPluz2zLvIJHBKrTA</link><description></description><content:encoded><![CDATA[人人学懂免疫学：第十八期]]></content:encoded><pubDate>Sat, 13 Mar 2021 06:21:47 +0800</pubDate></item><item><title>人人学懂免疫学：第十九期</title><link>https://mp.weixin.qq.com/s/psBJDWKVB5YvHQKh4-IFxQ</link><description></description><content:encoded><![CDATA[人人学懂免疫学：第十九期]]></content:encoded><pubDate>Sat, 13 Mar 2021 06:21:47 +0800</pubDate></item><item><title>人人学懂免疫学：第二十期</title><link>https://mp.weixin.qq.com/s/7TVs_3z8_EWEwpx-f21MRg</link><description></description><content:encoded><![CDATA[人人学懂免疫学：第二十期]]></content:encoded><pubDate>Sat, 13 Mar 2021 06:21:47 +0800</pubDate></item><item><title>人人学懂免疫学：第十一期</title><link>https://mp.weixin.qq.com/s/PHrFpn8bg7G7uLuMTu0GYA</link><description></description><content:encoded><![CDATA[人人学懂免疫学：第十一期]]></content:encoded><pubDate>Fri, 12 Mar 2021 06:51:00 +0800</pubDate></item><item><title>人人学懂免疫学：第十二期</title><link>https://mp.weixin.qq.com/s/6WoFilE-SYJmpLdQtxgqPg</link><description></description><content:encoded><![CDATA[人人学懂免疫学：第十二期]]></content:encoded><pubDate>Fri, 12 Mar 2021 06:51:00 +0800</pubDate></item></channel></rss>